{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:13:07Z","timestamp":1767676387527},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1988,12,1]],"date-time":"1988-12-01T00:00:00Z","timestamp":596937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":9867,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[1988,12]]},"DOI":"10.1038\/ki.1988.258","type":"journal-article","created":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T16:39:46Z","timestamp":1180543186000},"page":"840-844","source":"Crossref","is-referenced-by-count":45,"title":["Oral calcitriol and calcium: Efficient therapy for uremic hyperparathyroidism"],"prefix":"10.1016","volume":"34","author":[{"given":"L. Darryl","family":"Quarles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giora A.","family":"Davidai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve J.","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy W.","family":"Bartholomay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Lobaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.1988.258_bb0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198607173150304","article-title":"Calcium carbonate as a phosphate binder in patients with chronic renal failure","volume":"315","author":"Slatopolsky","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1988.258_bb0015","first-page":"320","article-title":"Oral calcium carbonate as phosphate-binder in infants and children with chronic renal failure","volume":"12","author":"Alon","year":"1986","journal-title":"Miner Electrol Metab"},{"key":"10.1038\/ki.1988.258_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ki.1980.154","article-title":"Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy","volume":"18","author":"Massry","year":"1980","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1988.258_bb0025","series-title":"Vitamin D: Chemical Biochemical and Clinical Endocrinology of Calcium Metabolism","article-title":"Prospective, double-blind trial with calcitriol in the prophylaxis of the bone disease in asymptomatic dialysis patients","author":"Coburn","year":"1982"},{"key":"10.1038\/ki.1988.258_bb0030","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1136\/bmj.282.6280.1919","article-title":"Double-blind trial of oral 1,25 dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis","volume":"282","author":"Memmos","year":"1981","journal-title":"Br Med J"},{"key":"10.1038\/ki.1988.258_bb0035","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/0003-4819-88-6-774","article-title":"1,25 dihydroxycholecalciferol effects in chronic dialysis: A double-blind controlled study","volume":"88","author":"Berl","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.1988.258_bb0040","first-page":"539","article-title":"Heterogeneity of secondary hyperparathyroidism in uremic patients on dialysis","volume":"30","author":"Coburn","year":"1982","journal-title":"Clin Res"},{"key":"10.1038\/ki.1988.258_bb0045","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperthyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1988.258_bb0050","series-title":"J Bone Miner Res","first-page":"374","article-title":"Intravenous calcitriol: Effects in severe secondary hyperparathyroidism","author":"Norris","year":"1986"},{"key":"10.1038\/ki.1988.258_bb0055","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/ki.1973.40","article-title":"Study of intestinal absorption of calcium in patients with renal failure","volume":"3","author":"Coburn","year":"1973","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1988.258_bb0060","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1172\/JCI108362","article-title":"Jejunal and ileal calcium absorption in patients with chronic renal disease, effect of 1-hydroxycholecalciferol","volume":"57","author":"Vergne-Marini","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1988.258_bb0065","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two site immunoradiometric assay for parathyrin hormone and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"10.1038\/ki.1988.258_bb0070","series-title":"Nichols Institute Reference Laboratories","article-title":"Immunoradiometric assay for intact PTH: A new generation of PTH assay for assessment of parathyroid function","author":"Pandiun","year":"1987"},{"key":"10.1038\/ki.1988.258_bb0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/jcem-58-1-91","article-title":"A micro assay for 1,25 dihydroxy vitamin D, not requiring high performance liquid chromatography: Application to clinical studies","volume":"58","author":"Reinhardt","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.1988.258_bb0080","series-title":"Primer of Biostatistics","first-page":"317","author":"Glantly","year":"1987"},{"key":"10.1038\/ki.1988.258_bb0085","series-title":"Nonparametric Studies for the Behavioral Sciences","first-page":"213","author":"Sigeel","year":"1956"},{"key":"10.1038\/ki.1988.258_bb0090","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI112666","article-title":"Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure","volume":"78","author":"Lopez-Hilker","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1988.258_bb0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jcem-54-1-172","article-title":"Abnormal regulation of parthyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure","volume":"54","author":"Brown","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.1988.258_bb0100","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/jcem-56-3-572","article-title":"Four-parameter model of the sigmoid relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue","volume":"56","author":"Brown","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.1988.258_bb0105","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.82.12.4270","article-title":"Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells","volume":"82","author":"Silver","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.1988.258_bb0110","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI112714","article-title":"Regulation of vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat","volume":"78","author":"Silver","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1988.258_bb0115","first-page":"302","article-title":"Dynamic behavior of plasma phosphate in chronic dialysis patients","volume":"28","author":"Sugisaki","year":"1982","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1038\/ki.1988.258_bb0120","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ki.1982.227","article-title":"Parathyroid function in persistent hyperparathyroidism: Relationship to gland size","volume":"22","author":"McCarron","year":"1982","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1988.258_bb0125","first-page":"G209","article-title":"Duodenal aluminum absorption in the rat: Effect of vitamin D","volume":"249","author":"Adler","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.1988.258_bb0130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF02405070","article-title":"Continuous infusion of 1,25-dihydroxy vitamin D3 stimunlate bone turnover in the normal young mouse","volume":"35","author":"Marie","year":"1983","journal-title":"Calcif Tissue Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815344318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815344318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T19:45:55Z","timestamp":1635536755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815344318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1988,12]]}},"alternative-id":["S0085253815344318"],"URL":"https:\/\/doi.org\/10.1038\/ki.1988.258","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[1988,12]]}}}